[Use of a methyl hydrazine derivative in the treatment of Hodgkin's disease].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D006834:Hydrazines
Utilisation d'un dérivé de la méthyl hydrazine dans le traitement de la maladie de Hodgkin.